Press Releases

 Filter by Provider

Leuven, Belgium, October 22, 2025. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated to transforming patients’ lives with best-in-class medicines, today announced that it will present preclinical data from its FGFR3, SMARCA2 and P53 Y220C small molecules programs in 3 posters at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place October 22-26, 2025, in Boston.

A Journey From Escape To Acceptance, Where Even Rivals Can Become Companions

A Gripping Mystery Rooted in Love, Loss, and Relentless Pursuit of the Truth

Spine Health & Wellness Expands DFW Patient Access with New Digital StrategyEstablished clinics in Irving, Bedford, and Grapevine enhance online...

October 22, 2025 -- Flexible Payment Plans and Same-Day Approval Make Roof Replacement Affordable for Northwest Illinois and Southern Wisconsin Families

October 22, 2025 -- Kirkus Professional Book Reviewers said: "Graham's new book is an intriguing and informative 'must read' from a woman who is probably the best-informed American on the terrifying realities concerning Vladimir Putin's motivations.

October 22, 2025 -- The Laonson Pill Cutter, a precise and hygienic cutting solution, is launching globally through the crowdfunding platform Kickstarter

October 22, 2025 -- Anthony "Amp" Elmore redefines Black Memphis History as global, spiritual, and cinematic, fusing Buddhism, kickboxing, & diplomacy. His archive links MLK, Ambedkar, Elvis, Odinga & the Black Orange Mound community in a movement of truth & reclamation

October 22, 2025 -- Chaikin Trial Group is now BBB® Accredited, reinforcing 25+ years of trusted legal service for injury victims across NYC, Long Island & Westchester.

October 22, 2025 -- Aether Pro Exchange integrates behavioral AI to personalize decision-making and strengthen risk awareness across its trading ecosystem.

October 22, 2025 -- This race-inspired robotic floor from Tennant cleaner is turning heads—and keeping floors sparkling clean—at one of Fort Worth's most unique museums.

October 22, 2025 -- Blending bold artistry, Cuban-American roots, and business savvy, April Paige launches a vibrant online destination for original artwork, exclusive prints, and curated interior design finds.

London, UK – 22 October 2025 – Elevara Medicines (“Elevara”), a clinical-stage biotech developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases, today announced the close of a $70 million Series A financing. The round was co-led by Forbion and Sofinnova Partners, with participation from founding investor, Monograph Capital.

But the real question is not ​ which AI wins the next trade ​—it’s ​ what happens to everyone else ​?

Amidst the volatile cryptocurrency market, more and more investors are seeking more stable, sustainable, and passive income options. An innovative cloud mining platform called FuturoMining is quietly changing the game.

Istanbul, Turkey--(Newsfile Corp. - October 22, 2025) - To better serve the growing number of patients traveling to Turkiye for...

London, October 2025—Ripple, the world’s leading blockchain-based payments technology company, today announced the launch of a new international partnership aimed at further expanding the adoption of its core digital asset, XRP, within the global financial system. As a strategic partner, cloud computing and blockchain infrastructure service provider LeanHash will join the Ripple ecosystem to provide high-performance, green, and secure computing power support for the global circulation and operation of XRP.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced the presentation of new analyses from the Phase 2b ELEVATE IPF trial of deupirfenidone (LYT-100) for the treatment of idiopathic pulmonary fibrosis (IPF). The data show that the favorable safety and efficacy profile of deupirfenidone was consistent across age groups, including in patients aged 75 years and older. These findings, presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting, suggest that deupirfenidone may address a key gap in the treatment of IPF, as older patients have historically been less likely to be treated, largely due to tolerability challenges.1,2 These data further reinforce deupirfenidone’s differentiated profile and support its potential to meaningfully improve care for this vulnerable population.

Press ReleaseGBI selects Nokia to build new network for faster, more resilient connectivity across the Middle East

Cincinnati, Ohio--(Newsfile Corp. - October 22, 2025) - Horenstein, Nicholson & Blumenthal, a leading Ohio social security disability and workers'...

PARIS, FRANCE, 22 October 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the year to date and the third quarter of 2025.

Santa Monica, California--(Newsfile Corp. - October 22, 2025) - Koster Communications, a boutique marketing agency specializing in brand positioning, public...

The 2025 International Jump Rope Masters Tournament took place successfully in Gaojing Town, Baoshan District, Shanghai, from October 17 to 20. Making its debut in China, this international event brought together over 230 top-tier athletes from 12 countries and regions worldwide—including nearly 60 overseas jump rope masters—jointly presenting a jump rope gala that blends elite competitiveness with high viewing appeal.

Toobit is pleased to announce the upcoming listing of KYX (KYX) for spot trading in the Assessment Zone, commencing on October 22, 2025 at 8:00 AM (UTC).

SPONSORED CONTENT -- (StatePoint) With Apple’s latest smartphone lineup featuring the biggest physical redesign in years, you may be wondering if it’s time for a mobile device upgrade.

SPONSORED CONTENT -- (StatePoint) A woman’s sexual and reproductive health needs evolve throughout her life. What’s important at age 25 may look very different at 55. But are women talking about their experiences?

Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study

Munich, 22.10.2025 – A2MAC1 and ZeBeyond announce a strategic collaboration that introduces a simulation-first benchmarking platform for electric powertrains. The new approach enables OEMs and Tier 1 suppliers to validate vehicle efficiency and performance within days – compared to traditional teardown and dynamometer testing that can take more than a year.

PARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies. The anticipated acquisition is focused on the lead Phase I/II program ICT01 in first line acute myeloid leukemia (AML)3 patients who are ineligible for intensive chemotherapy. ICT01 is a first-in-class monoclonal antibody targeting BTN3A, a key immune-regulatory molecule broadly expressed across cancer, and received Orphan Drug Designations from the U.S. Food and Drug Administration and European Medicines Agency in July 2025.

Inaugural season kicks off with outdoor shows at the Atlanta Botanical Garden on October 30th; Performances will include several dates and locations

Washington, D.C.--(Newsfile Corp. - October 22, 2025) - On October 18, the "Guizhou Intangible Cultural Heritage Entering American Campuses" event,...

Oct 22, 2025 - Mission AI today launched Unee, an AI plush built around emotional recognition and a multi-layer memory model to provide emotional support and human-like understanding.

The transaction marks the sale of a 1.16-acre parcel at 3904 Sedgebrook Street in High Point, North Carolina, to Valley Land Real Estate, LLC, a Culver’s franchisee. M Square Commercial represented Hutton in the retail land disposition that supports Culver’s continued expansion across the Southeast.

Wuhu, China, October 22, 2025 -- On the afternoon of October 19, smooth jazz set the tone at the iCAUR (one of Chery Automobile’s overseas brands) International User Summit. The brand opened a global session on Classic, Co-creating, and Innovation, welcoming over a hundred partners from around the world.

Colorado, United States, October 22, 2025 -- According to industry sources, TGCoin, a technology company specializing in trusted digital infrastructure, and the Finstar Foundation are set to formally sign a global strategic cooperation agreement on October 26, 2025 . The partnership will focus on three key areas — AI, cybersecurity, and inclusive intelligence — with the shared goal of building a safer, more transparent, and socially responsible digital ecosystem.

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced the pricing of an underwritten public offering of 4,196,000 shares of the Company’s Class A common stock (the “Offering”). The shares of Class A common stock are being sold at a public offering price of $7.15 per share, before underwriting discounts and commissions. All of the shares in the Offering are to be sold by the Company. The gross proceeds to Owlet from the Offering are expected to be approximately $30.0 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 629,400 shares of Class A common stock at the public offering price less the underwriting discounts and commissions. The Offering is expected to close on or about October 23, 2025, subject to the satisfaction of customary closing conditions.

Eligo has published a peer-reviewed paper addressing revote, low coercion and verifiable online voting, recently presented at the international conference E-Vote-ID 2025 in Nancy, France.

New framework enables law firms to build secure, domain-specific AI agents that draft, review, and route legal documents autonomously—without compromising confidentiality.

Intuitive Strategies unveils an innovative program designed to help entrepreneurs harness their intuition for confident decision-making and impactful leadership.

Fintech platform eliminates hidden fees, long-term contracts, and confusing rate structures to bring clarity and trust back to invoice financing.

The new app allows Indian users to launch European and American roulette directly from their smartphone screen without downloads, registration, or restrictions.

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it will deliver an oral presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held from October 22-26, 2025, in Boston, MA.